Clinical Trial Update: Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on CSJ148 in stem cell transplant patients assessing efficacy and safety for HCMV; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Hcmv Disease

Drugs mentioned

• CSJ148

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: HCMV | Phase 2 | Status: COMPLETED | Results posted: 2018-02-26